Title |
Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care
|
---|---|
Published in |
Journal of Antimicrobial Chemotherapy (JAC), September 2010
|
DOI | 10.1093/jac/dkq336 |
Pubmed ID | |
Authors |
Christopher C. Butler, Kerenza Hood, Mark J. Kelly, Herman Goossens, Theo Verheij, Paul Little, Hasse Melbye, Antoni Torres, Sigvard Mölstad, Maciek Godycki-Cwirko, Jordi Almirall, Francesco Blasi, Tom Schaberg, Peter Edwards, Ulla-Maija Rautakorpi, Helena Hupkova, Joseph Wood, Jacqui Nuttall, Samuel Coenen |
Abstract |
Acute cough/lower respiratory tract infection (LRTI) is one of the commonest reasons for consulting and antibiotic prescribing. There are theoretical reasons why treatment with particular antibiotic classes may aid recovery more than others, but empirical, pragmatic evidence is lacking. We investigated whether treatment with a particular antibiotic class (amoxicillin) was more strongly associated with symptom score resolution and time to patients reporting recovery than each of eight other antibiotic classes or no antibiotic treatment for acute cough/LRTI. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 50% |
Australia | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 50% |
Scientists | 2 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Korea, Republic of | 1 | 2% |
Ireland | 1 | 2% |
United Kingdom | 1 | 2% |
Belgium | 1 | 2% |
Russia | 1 | 2% |
Unknown | 46 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 22% |
Student > Master | 7 | 14% |
Student > Ph. D. Student | 6 | 12% |
Student > Doctoral Student | 5 | 10% |
Professor | 3 | 6% |
Other | 13 | 25% |
Unknown | 6 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 47% |
Computer Science | 5 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
Immunology and Microbiology | 2 | 4% |
Social Sciences | 2 | 4% |
Other | 6 | 12% |
Unknown | 9 | 18% |